Standout Papers

ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor 2008 2026 2014 2020 1.5k
  1. ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor (2008)
    Christin Tse, Alexander R. Shoemaker et al. Cancer Research

Immediate Impact

5 by Nobel laureates 40 from Science/Nature 119 standout
Sub-graph 1 of 19

Citing Papers

Alveolar fibroblast lineage orchestrates lung inflammation and fibrosis
2024 StandoutNature
Cellular senescence in normal physiology
2024 StandoutScience
2 intermediate papers

Works of Sha Jin being referenced

ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
2008 Standout

Author Peers

Author Last Decade Papers Cites
Sha Jin 1607 289 150 607 28 2.1k
Matthew R. Janes 2158 242 158 584 26 2.7k
Lisa Roberts 1381 203 84 609 20 1.9k
Anna Scuto 1385 299 134 662 30 2.2k
Michael J. Mitten 1858 355 104 818 27 2.7k
Evelyn McKeegan 1254 291 74 700 41 2.0k
Alexander R. Shoemaker 2192 230 120 890 22 2.9k
Gaurav S. Choudhary 1013 241 88 442 34 1.7k
Hans-Guido Wendel 2039 190 105 533 20 2.5k
Rachael E. Hawtin 1271 170 82 633 53 2.0k
Baskaran Rajasekaran 1544 236 196 551 25 2.1k

All Works

Loading papers...

Rankless by CCL
2026